Tupy (TUPY3) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Net revenue reached R$2.6 billion in Q2 2025, down 6% year-over-year, mainly due to a 10% drop in sales volumes, especially in commercial vehicles in the US and Europe.
Adjusted EBITDA was R$210 million, with margin falling to 8% from 14% in 2Q24, reflecting lower volumes and price adjustments.
Net income rose 33% year-over-year to R$24 million, aided by improved financial results and favorable currency effects.
Strategic market consolidation, new business segments, and MWM growth contributed to revenue diversification and higher value-added offerings.
Capacity reduction and efficiency plans advanced to address global uncertainties and weaker commercial vehicle demand.
Financial highlights
Gross margin declined to 13.9% from 19.4% year-over-year, mainly due to lower volumes and fixed cost dilution.
Adjusted EBITDA for Q2 2025 was R$210 million; net debt stood at R$2.6 billion (2.45x LTM adjusted EBITDA); cash position at R$1.44 billion.
Distribution and energy/decarbonization units now represent 30% of domestic revenue and 15% of total revenue.
SG&A expenses increased 4% to R$250 million.
Net financial expense improved to R$35 million from R$176 million in 2Q24, aided by positive exchange rate variations and hedging.
Outlook and guidance
Macroeconomic uncertainties and trade barriers are expected to continue impacting demand in key markets, especially commercial vehicles in the US and Europe.
Capacity optimization and efficiency initiatives are expected to yield R$100 million in annual gains by 2026 and R$180 million from 2027.
EBITDA margin is projected to improve by at least two percentage points by end-2026, with plant occupancy targeted at 80%.
Focus on expanding in high-growth segments such as energy, decarbonization, and aftermarket.
Significant sales growth and improved profitability expected in 2026 from new long-term contracts.
Latest events from Tupy
- Record EBITDA and cash flow offset lower revenue; new contracts and bioplants drive growth.TUPY3
Q2 20242 Feb 2026 - Record cash flow and margin gains offset revenue and net income declines amid weak demand.TUPY3
Q3 202414 Jan 2026 - Record EBITDA and cash flow achieved despite lower sales, with margin gains and strong outlook.TUPY3
Q4 202423 Dec 2025 - Revenue down 4% and net loss, but aftermarket and gensets segments showed strong growth.TUPY3
Q1 202520 Nov 2025 - Revenue and EBITDA fell, but record cash flow and new segments support future margin gains.TUPY3
Q3 202513 Nov 2025